[Clinical characteristics and outcome of 216 indolent B cell lymphomas]
- PMID: 26876256
- PMCID: PMC7342303
- DOI: 10.3760/cma.j.issn.0253-2727.2016.01.012
[Clinical characteristics and outcome of 216 indolent B cell lymphomas]
Figures
Similar articles
-
Indolent lymphomas of mature B lymphocytes.Hematol Oncol Clin North Am. 2009 Aug;23(4):769-90. doi: 10.1016/j.hoc.2009.04.010. Hematol Oncol Clin North Am. 2009. PMID: 19577169 Review.
-
Evaluation of different methods in the follow-up of patients with indolent types of primary cutaneous lymphomas.Br J Dermatol. 2012 Jun;166(6):1295-300. doi: 10.1111/j.1365-2133.2012.10896.x. Br J Dermatol. 2012. PMID: 22356095
-
Pathology of indolent B-cell neoplasms other than follicular lymphoma.J Clin Exp Hematop. 2014;54(1):11-22. doi: 10.3960/jslrt.54.11. J Clin Exp Hematop. 2014. PMID: 24942942 Review.
-
Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki67 expression identifies a better prognosis subgroup.Haematologica. 2005 Feb;90(2):200-6. Haematologica. 2005. PMID: 15710572
-
[Diagnostic key points and recent researches on the indolent B-cell lymphomas].Rinsho Ketsueki. 2011 Oct;52(10):1619-27. Rinsho Ketsueki. 2011. PMID: 21971239 Review. Japanese. No abstract available.
References
-
- Isaacson PG, Piris MA, Berger F, et al. Splenic B-cellmarginal zone ymphoma, in WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues[M] 4th ed. Lyon: IARC Press; 2008. pp. 218–219.
-
- Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma[J] J Clin Oncol. 2007;25(5):579–586. - PubMed
-
- Hermine O, Lefrère F, Bronowicki JP, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection[J] N Engl J Med. 2002;347(2):89–94. - PubMed
-
- Solal-Celigny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index[J] Blood. 2004;104(5):1258–1265. - PubMed